Today: 7 February 2026
Subscribe
Browse Category

LSE:AZN.L News 8 December 2025 - 31 January 2026

AstraZeneca share price: $18.5 billion China obesity-drug deal puts AZN stock in focus for Monday

AstraZeneca share price: $18.5 billion China obesity-drug deal puts AZN stock in focus for Monday

AstraZeneca agreed to license obesity drug candidates from CSPC Pharmaceutical in a deal worth up to $18.5 billion, paying $1.2 billion upfront. AstraZeneca shares rose 0.65% in London, while CSPC shares fell nearly 12% in Hong Kong. The deal gives AstraZeneca rights outside Greater China and includes a once-monthly GLP-1/GIP agonist entering Phase I trials. AstraZeneca will also delist its ADS from Nasdaq and move to the NYSE.
31 January 2026
··
Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

Updated: 8 December 2025 – UK market close The UK stock market has quietly turned into one of 2025’s star performers. The FTSE 100 is trading around 9,660 and has delivered a total return of roughly 20–23% year‑to‑date, one of its best years since the aftermath of the financial crisis.Investors Chronicle+2Wealth DFM+2 At the same time, the Bank of England (BoE) has held Bank Rate at 4% since August, with inflation down to about 3.6% and markets heavily betting on a first quarter‑point cut to 3.75% at the 18 December meeting. A Reuters poll in mid‑November found nearly 80% of economists expect that cut, with many
8 December 2025
·········

Stock Market Today

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

7 February 2026
Netflix shares rose 1.6% to $82.20 Friday as the Justice Department expanded its antitrust review of the company’s planned $82.7 billion Warner Bros Discovery acquisition. A Wall Street Journal report said investigators are probing possible anti-competitive tactics. Director Reed Hastings reported a transfer of 241,944 shares via a family trust, according to an SEC filing.
Go toTop